DIP2B as a Prognostic Biomarker and Immunotherapy Target: Insights from Pan-Cancer Analysis

Applied Biochemistry and Biotechnology 2026

View at publisher
Authors: Hai Bai, Yue Cao, Guozheng Wei, Wanqing Xu, Richard Mprah, Li Cui, Mingming Wang
DOI: 10.1007/s12010-025-05542-4
Cited by: 1
References: 47

Fields of Study & Subjects

Epigenetics and DNA Methylation Ferroptosis and cancer prognosis Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Applied Biochemistry and Biotechnology
Publisher
Springer Science and Business Media LLC
Volume
198
Issue
2
Pages
1231–1260
Publication date
4 January 2026
Language
EN